“…expected that the antiobesity effect induced by GW0742 is important for its protective cardiovascular effects. However, we have reported changes in vascular function in other models unrelated to changes in body fat or body weight [17][18][19] and even in in-vitro studies [21], suggesting that direct vascular effects may also play a significant role. The main factors that impair endothelial function in obesity, such as increased blood pressure, hyperglycemia, insulin resistance, hypertriglyceridemia, and systemic inflammation, were normalized by PPARb activation.…”